Sixuan Cheng
Overview
Explore the profile of Sixuan Cheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang S, Zheng C, Cheng S, Wen L, Li P, Li J, et al.
Mol Ther Nucleic Acids
. 2025 Mar;
36(1):102483.
PMID: 40083648
Aptamers are single-stranded oligonucleotides with specific spatial structures. They have been widely used in preclinical studies because of their high affinity and specificity for various biological targets. AS1411, an aptamer...
2.
Cheng B, Xia X, Cheng S, Han C, Sun F, Fu Z, et al.
Adv Mater
. 2025 Mar;
:e2500357.
PMID: 40066517
Obtaining controllable active layer morphology plays a significant role in boosting the device performance of organic solar cells (OSCs). Herein, a quaternary strategy, which incorporates polymer donor D18-Cl and small...
3.
Long X, Cheng S, Lan X, Wei W, Jiang D
Eur J Nucl Med Mol Imaging
. 2025 Jan;
PMID: 39800806
As the smallest antibody fragment with specific binding affinity, nanobody-based nuclear medicine has demonstrated significant potential to revolutionize the field of precision medicine, supported by burgeoning preclinical investigations and accumulating...
4.
Wang Z, Song X, Cheng S, Jiang D, Zheng D, Lan X, et al.
Mol Pharm
. 2025 Jan;
22(2):817-826.
PMID: 39797803
Acute myocardial infarction (MI) remains a leading cause of mortality worldwide, with inflammatory and reparative phases playing critical roles in disease progression. Currently, there is a pressing need for imaging...
5.
Cheng S, Long X, Zhang Y, Lan X, Jiang D
Small
. 2024 Nov;
21(2):e2406950.
PMID: 39530610
Cancer vaccines are emerged as a beacon of hope in the fight against cancer. However, the lack of effective methods to directly observe their in vivo behavior and monitor therapeutic...
6.
Cheng S, Jiang D, Lan X, Liu K, Fan C
Biomed Pharmacother
. 2024 May;
175:116651.
PMID: 38692062
Voltage-gated potassium channel 1.3 (Kv1.3) has emerged as a pivotal player in numerous biological processes and pathological conditions, sparking considerable interest as a potential therapeutic target across various diseases. In...
7.
Cheng S, Jiang D, Li M
Am J Nucl Med Mol Imaging
. 2024 Jan;
13(6):295-299.
PMID: 38204607
Radionuclide antibody conjugate (RAC) is a promising diagnostic and therapeutic tool. It combines radionuclides and antibodies by connecting arms and chelating agents, offering precise targeting and potent killing of tumor...
8.
Etchegoyen C, Keller G, Mrad S, Cheng S, Di Girolamo G
Curr Clin Pharmacol
. 2018 Feb;
12(4):210-222.
PMID: 29473523
Background: The most common acquired cause of Long QT syndrome (LQTS) is drug induced QT interval prolongation. It is an electrophysiological entity, which is characterized by an extended duration of...